Alibaba
BABA
Adobe
ADBE
Qualcomm
QCOM
4
Netflix
NFLX
5
Salesforce
CRM
US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 1.210
- -0.060-4.72%
Close May 6 16:00 ET
7.89MMarket Cap-0.52P/E (TTM)
1.270High1.180Low141.41KVolume1.270Open1.270Pre Close173.61KTurnover2.55%Turnover RatioLossP/E (Static)6.52MShares10.04952wk High-1.02P/B6.72MFloat Cap0.72352wk Low--Dividend TTM5.55MShs Float787.500Historical High--Div YieldTTM7.09%Amplitude0.723Historical Low1.227Avg Price1Lot Size
Brainstorm Cell Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 55.55%-9.09M | 80.17%-1.05M | 48.53%-3.3M | 75.17%-1.68M | 23.16%-3.06M | -5.89%-20.46M | -13.70%-5.29M | -32.14%-6.41M | -10.50%-6.78M | -8.08%-3.99M |
| Net income from continuing operations | 32.39%-11.62M | 46.70%-2.97M | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M |
| Operating gains losses | 96.75%-147K | -219.49%-282K | 91.72%-394K | ---411K | --940K | ---4.53M | --236K | ---4.76M | ---- | ---- |
| Depreciation and amortization | -9.43%240K | -19.70%53K | -9.23%59K | -4.48%64K | -4.48%64K | -7.02%265K | -5.71%66K | -7.14%65K | -5.63%67K | -9.46%67K |
| Change In working capital | 440.12%1.69M | 4,646.34%1.95M | 58.07%-434K | 140.38%1.01M | -183.43%-836K | -116.59%-496K | 153.25%41K | -167.08%-1.04M | -680.97%-2.5M | -8.33%1M |
| -Change in receivables | ---- | ---- | -56.81%149K | -44.12%133K | 120.90%121K | ---- | ---- | -24.51%345K | -20.93%238K | -279.26%-579K |
| -Change in prepaid assets | 184.42%401K | ---- | ---- | ---- | ---- | ---475K | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 800.00%1.23M | 953.30%1.92M | 53.63%-613K | 132.72%882K | -157.47%-954K | -106.99%-176K | 258.26%182K | -218.04%-1.32M | -531.36%-2.7M | 87.15%1.66M |
| -Change in other current liabilities | -65.16%54K | -90.83%31K | 151.72%30K | 91.30%-4K | 96.20%-3K | 126.09%155K | 550.00%338K | -70.59%-58K | 90.71%-46K | 32.48%-79K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 55.55%-9.09M | 68.10%-1.05M | 48.53%-3.3M | 75.17%-1.68M | 23.16%-3.06M | -5.89%-20.46M | 29.32%-3.29M | -32.14%-6.41M | -10.50%-6.78M | -8.08%-3.99M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -99.45%12K | -93.88%12K | 0 | 0 | 0 | 119.74%2.19M | -81.12%196K | -9.09%-12K | 133.33%4K | 11,894.12%2.01M |
| Net PPE purchase and sale | 166.67%12K | ---- | ---- | ---- | ---- | 37.93%-18K | --0 | -1,700.00%-18K | ---- | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | 115.29%2.21M | -81.12%196K | 160.00%6K | -42.86%4K | 25,162.50%2.01M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -99.45%12K | -93.88%12K | --0 | --0 | --0 | 119.74%2.19M | -81.12%196K | -9.09%-12K | 133.33%4K | 11,894.12%2.01M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -58.02%7.97M | -68.44%1.06M | 0 | -17.53%4.37M | -21.39%2.54M | 7,873.95%18.98M | 1,308.40%3.35M | 7.1M | 5.3M | 3.23M |
| Net common stock issuance | -58.02%7.97M | -68.44%1.06M | --0 | -17.53%4.37M | -21.39%2.54M | 7,873.95%18.98M | 1,308.40%3.35M | --7.1M | --5.3M | --3.23M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -58.02%7.97M | -68.44%1.06M | --0 | -17.53%4.37M | -21.39%2.54M | 7,873.95%18.98M | 1,308.40%3.35M | --7.1M | --5.3M | --3.23M |
| Net cash flow | ||||||||||
| Beginning cash position | 92.36%1.49M | -71.44%349K | 568.13%3.65M | -52.45%961K | 92.36%1.49M | -95.91%772K | -70.51%1.22M | -93.94%546K | -86.66%2.02M | -95.91%772K |
| Current changes in cash | -256.24%-1.11M | -91.63%22K | -588.02%-3.3M | 282.17%2.69M | -141.95%-524K | 103.94%713K | 107.80%263K | 113.91%676K | 76.00%-1.48M | 133.71%1.25M |
| End cash Position | -75.02%371K | -75.02%371K | -71.44%349K | 568.13%3.65M | -52.45%961K | 92.36%1.49M | 92.36%1.49M | -70.51%1.22M | -93.94%546K | -86.66%2.02M |
| Free cash flow | 55.59%-9.09M | 68.10%-1.05M | 48.67%-3.3M | 75.17%-1.68M | 23.16%-3.06M | -5.82%-20.48M | 29.32%-3.29M | -32.49%-6.43M | -10.16%-6.78M | -7.82%-3.99M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call